This extensive portfolio includes the following products:
These cells are basically differentiated, adherent and predominantly derived from tissue. In culture, they retain most of the special structures and functions such as in vivo cells. Cells from Clonetics are subject to strict quality criteria. Thus, all cells are HIV-1, hepatitis B and C negative and free from mycoplasma contamination. Available either "cryopreserved", in cell culture flasks or trays, or as pellets in RNAlater®.
The Poetics™ stem cell, progenitor cell and media product line includes a collection of human and animal cells derived from hematopoietic, body fat and neuronal systems.
Poietics® primary human immune cells are taken either from the peripheral blood or the umbilical cord. The purity of the removed cells is checked by flow cytometry. The donors are tested for the presence of HIV-1, hepatitis B and C virus.
AllCells has been the leading provider of high quality human primary blood and bone marrow cells for over 20 years. In February 2019, Lonza and AllCells entered into a collaboration to manufacture and globally commercialize a broad range of hematopoietic primary cells. This partnership extends Lonza's range of hematopoietic cells and now allows users to choose from a very wide range of high-quality primary cells. AllCells is known for its high-quality cells and flexibility to adapt to unique customer requirements. Comprehensive documentation is provided to comply with FDA and EU regulations for the collection of tissues and cells for human use. The donors will be examined in accordance with GMP, FDA, CFR 21CFR1271 and EU Directives 2004/23 / EC and 2006/17 / EC.s.
The new CellBio service from Lonza offers optimal individual cell support for your research. This includes cell isolation from tissues, characterization of cells, modification of existing catalog products, services such as cell banking and cell expansion, and immortalization of cells.
CELLutions Biosystems (a company of CEDARLANE) builds a bridge between the academic and biopharmaceutical community with the goal of making new and innovative development tools available for basic research, drug development and therapeutic applications. This provides the opportunity to better understand complex human diseases and to develop new and effective treatments for them.
More information can be found at: br>Research Products & Biochemicals / Defined Cell Lines (CELLutions)